Management of Vertebral Fragility Fracture in Older People: Recommendations from a Spanish Consensus of Experts

• Published in: Geriatrics (Basel) Vol. 9; no. 2; p. 24
• Main Authors: Castañeda, Santos, Navarro Ceballos, Carmen, Usón Jaeger, Jaqueline, de Miguel Benadiba, Carolina, Gómez Martín, Esteban, Martínez Díaz-Guerra, Guillermo, Alvarez-Galovich, Luis
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-04-2024; MDPI
• Subjects: Aged patients; aging; Care and treatment; Clinical medicine; Clinical practice guidelines; Complications and side effects; comprehensive assessment; Diagnostic tests; expert consensus; Falls; Fractures; Frailty; Hospitals; Life expectancy; Metabolism; Mortality; older patients; Older people; Osteoporosis; Qualitative research; Quality of life; Questionnaires; Risk assessment; Society; Spine; vertebral fractures; Spain; older patients; comprehensive assessment; expert consensus; aging; osteoporosis; vertebral fractures
• ISSN: 2308-3417; 2308-3417
• DOI: 10.3390/geriatrics9020024

Vertebral fragility fractures (VFF) pose a challenge for appropriate care. The aim of this study was to develop consensus recommendations for the management of VFF in older people from a multidisciplinary approach. Specialists in osteoporosis belonging to different scientific societies reviewed the main clinical practice guidelines published in Spain in 2014. Thirty-five recommendations for the management of VFF were evaluated by seven experts using an anonymous survey. Consensus was defined as 80% of responses of 8 (agree) and 9 (strongly agree) on a Likert scale. Consensus was achieved in 22 recommendations (62.8%). The experts agreed on the need for anamnesis, clinical assessment, and laboratory tests, including erythrocyte sedimentation rate, proteinography, and the assessment of levels of calcium, vitamin D, alkaline phosphatase, and thyroid-stimulating hormone. Optional tests, such as bone turnover markers (BTMs), magnetic resonance imaging, bone scintigraphy, or using a fracture risk assessment tool (FRAX
), did not achieve an agreed consensus. Also, there was consensus regarding the administration of calcium/vitamin D supplements, the withdrawal of toxic habits, and personalized physical exercise. Participants agreed on the administration of teriparatide for 24 months and then a switch to denosumab or bisphosphonates in patients at high risk of fracture. Specialists in osteoporosis, primary care physicians, and geriatricians should be involved in the follow-up of patients with VFF. Although there was multidisciplinary agreement on diagnostic tests and non-pharmacological and pharmacological treatment in frail older people, therapeutic objectives should be individualized for every patient. In addition to the specific recommendations, close collaboration between the geriatrician and the primary care physician is essential for the optimal chronic management of frail patients with fragility fractures.